Views, 2007; 65: 181?17 27. Siegel BV, Morton JI: Vitamin C and immunity: influence of ascorbate on prostaglandin E2 synthesis and implications for natural killer cell activity. Int J Vitam Nutr Res, 1984; 54: 339?2 28. Padayatty SJ, Sun H, Wang Y et al: Vitamin C pharmacokinetics: implications for oral and intravenous use. Ann Intern Med, 2004; 140(7): 533?7 29. Mikirova N, Casciari J, Riordan N, Hunninghake R: Clinical experience with intravenous administration of ascorbic acid: achievable levels in blood for unique states of inflammation and disease in cancer individuals. J Transl Med, 2013; 11: 191 30. Riordan HD, Hunninghake RB, Riordan NH et al: Intravenous ascorbic acid: protocol for its application and use. P R Overall health Sci J, 2003; 22(3): 287?0 31. Du WD, Yuan ZR, Sun J et al: Therapeutic efficacy of high-dose vitamin C on acute pancreatitis and its possible mechanisms. Globe J Gastroenterol, 2003; 9(11): 2565?This perform is licensed below a Inventive Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseIndexed in: [Current Contents/Clinical Medicine] [SCI Expanded] [ISI Alerting System] [ISI Journals Master List] [Index Medicus/MEDLINE] [EMBASE/Excerpta Medica] [Chemical Abstracts/CAS] [Index Copernicus]CLINICAL RESEARCHMikirova N.A. et al.: Effect of high dose vitamin C on Epstein-Barr viral infection ?Med Sci Monit, 2014; 20: 725-32. Yeom CH, Jung GC, Song KJ: Alterations of terminal cancer patients’ healthrelated high quality of life following higher dose vitamin C administration. J Korean Med Sci, 2007; 22(1): 7?1 33. Jackson J, Riordan HD, Hunninghauke R, Riordan N: High dose intravenous vitamin C and lengthy time survival of a patient with cancer of the head and pancreas.152835-00-2 manufacturer J Ortho Med, 1995; 10: 87?eight 34.Boc-NH-PEG3 uses Riordan HD, Jackson J, Riordan N, Shultz M: High-dose intravenous vitamin C within the treatment of a patient with renal cell carcinoma on the kidney.PMID:23724934 J Ortho Med, 1998; 13: 72?3 35. Sherman DL, Keaney JF Jr, Biegelsen ES et al: Pharmacological conncentrations of ascorbic acid are necessary for the helpful impact on endothelial vasomotor function in hypertension. Hypertension, 2000; 35(four): 936?1 36. Kennes B, Dumont I, Brohee D et al: Effect of vitamin C supplements on cell-mediated immunity in old men and women. Gerontology, 1983; 29: 305?0 37. Anderson R, Dittrich OC: Effects of ascorbate on leucocytes: Part IV. Elevated neutrophil function and clinical improvement following oral ascorbate in 2 sufferers with chronic granulomatous illness. S Afr Med J, 1979; 1: 56476?0 38. Jain SK, Pemberton PW, Smith A et al: Oxidative strain in chronic hepatitis C: not just a feature of late stage illness. J Hepatol, 2002; 36(six): 805?1 39. Chen JY, Chang CY, Feng PH et al: Plasma vitamin C is reduced in postherpetic neuralgia sufferers and administration of vitamin C reduces spontaneous pain but not brush-evoked discomfort. Clin J Discomfort, 2009; 25(7): 562?9 40. Levy TE (ed.), Curing the Incurable: Vitamin C, Infectious Diseases, and Toxins. Bloomington: Xlibris corporation, 2002 41. Harakeh S, Jariwalla RJ, Pauling L: Suppression of human immunodeficiency virus replication by ascorbate in chronically and acutely infected cells. Proc Natl Acad Sci USA, 1990; 87: 7245?9 42. Cheng LL, Liu YY, Li B et al: An in vitro study on the pharmacological ascorbate remedy of influenza virus (abstract). Zhonghua Jie He He Hu Xi Za Zhi, 2012; 35(7): 520?3 43. Schencking M, Vollbracht C, Weiss G et al: Intravenous vitamin C within the therapy of shingles: results of a multicenter prosp.